ArticleIn vivo (Athens, Greece)

The Geriatric Nutritional Risk Index Predicts Tolerability of Lenvatinib in Patients With Hepatocellular Carcinoma.

Akiyoshi Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.